ロード中...
Overexpression of SET and MYND Domain-Containing Protein 2 (SMYD2) Is Associated with Tumor Progression and Poor Prognosis in Patients with Papillary Thyroid Carcinoma
BACKGROUNDS: SET and MYND domain-containing protein 2 (SMYD2), which is identified as a protein-lysine methyltransferase, plays a crucial role in the progression of some tumors such as bladder carcinoma. However, the clinical significance of SMYD2 in patients with papillary thyroid carcinoma (PTC) h...
保存先:
| 出版年: | Med Sci Monit |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
International Scientific Literature, Inc.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6198713/ https://ncbi.nlm.nih.gov/pubmed/30319138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.910168 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|